Dave Morgan - Concepedia

Author

Dave Morgan

Also Known As

D W Morgan, D W. Morgan, D. Morgan, D. W Morgan, D. W. Morgan, Dave Morgan, Dave Morgan (NETL); Tim Grant (NETL), Maj-Linda B. Selenica

158

Publications

27.9K

Citations

H-Index

123

Concepts

All Affiliations

University of South Florida USF Health Byrd Alzheimer's Institute Florida College Michigan State University Posit Science (United States)

About

Dave Morgan is an author at University of South Florida specializing in medicine, neuroscience, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	35	6.7K
2	Social Sciences	11	11	2.1K
3	Health Sciences	6	6	599
4	Natural Sciences	2	2	61
5	Education	1	1	10

Dave Morgan

Publications

21K

Citations

H-Index

Page 1

	Year	Citations
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy Maj-Linda B. Selenica, Milene L. Brownlow, Jeffy P. Jimenez, Neurodegenerative Diseases	2012	10.4K
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease Dave Morgan, David M. Diamond, Paul E. Gottschall, Nature VaccinationNeurodegenerative DiseasesAlzheimer's DiseaseMedicineMemory Loss	2000	1.5K
Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes Leigh A. Holcomb, Marcia N. Gordon, Eileen McGowan, Nature Medicine Neurodegenerative DiseasesMolecular NeuroscienceAlzheimer's DiseaseTransgenic Mouse ModelsDegenerative Pathology	1998	1.4K
Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. Donna M. Wilcock, Amyn M. Rojiani, Arnon Rosenthal, Journal of Neuroinflammation	2004	385
Behavioral Changes in Transgenic Mice Expressing Both Amyloid Precursor Protein and Presenilin-1 Mutations: Lack of Association with Amyloid Deposits Leigh A. Holcomb, Marcia N. Gordon, Paul Jantzen, Behavior Genetics	1999	349
Microglial Activation and β-Amyloid Deposit Reduction Caused by a Nitric Oxide-Releasing Nonsteroidal Anti-Inflammatory Drug in Amyloid Precursor Protein Plus Presenilin-1 Transgenic Mice Paul Jantzen, Karen E. Connor, Giovanni DiCarlo, Journal of Neuroscience Nitric OxideAbeta DepositsImmunologyNeurochemical BiomarkersAmyloid Precursor Protein	2002	343
Passive Amyloid Immunotherapy Clears Amyloid and Transiently Activates Microglia in a Transgenic Mouse Model of Amyloid Deposition Donna M. Wilcock, Amyn M. Rojiani, Arnon Rosenthal, Journal of Neuroscience	2004	289
LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice Daniel C. Lee, Justin Rizer, Maj-Linda B. Selenica, Journal of Neuroinflammation ImmunologyCell DeathVehicle InjectionsAmyloid Precursor ProteinNeuroinflammation	2010	285
Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation. Donna M. Wilcock, Giovanni DiCarlo, Debbi Henderson, PubMed ImmunologyAmyloid RemovalNeurochemical BiomarkersImmunotherapyActive Immunization	2003	267
Promotion of Physical Fitness and Prevention of Secondary Conditions for Children With Cerebral Palsy: Section on Pediatrics Research Summit Proceedings Eileen Fowler, Thubi H. A. Kolobe, Diane L. Damiano, Physical Therapy	2007	259

Page 1